ELVN Operating Cash Flow (Statement)
Enliven Therapeutics Inc · Operating Cash Flow (Statement)
ELVN Operating Cash Flow (Statement)
Latest reported-$66.94Mperiod ending
ELVN Cash from Operations (-$8.79M → -$66.94M)
Annual operating cash flow (statement)
High-resolution chart · PNG
ELVN operating cash flow (statement) history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -70,301,000 | |
| -73,192,000 | |
| -61,269,000 | |
| -32,077,000 | |
| -19,134,000 | |
| -8,529,000 | |
| -21,877,000 | |
| -8,777,000 | |
| -8,785,000 |